Sitemap
June 17, 2008 Articles
Filter by Available Specialty
- Allergan receives FDA approval for Trivaris injectable triamcinolone suspension
- Appropriate target for glycemic control debated
- Baseline elevated HER-2 extracellular domain level not predictive of lapatinib benefit
- Glaucoma risk assessment may be more useful if modifiable risk factors are identified
- Low-dose estrogen plus GH may optimize outcomes in patients with Turner Syndrome
- Nearly 95% of patients return to sports after Bankart procedure
- Prostaglandin monotherapy ideal for some glaucoma patients, physician says
- Thorough evaluation of glaucoma patients vital before refractive procedures